Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 601–700 of 1,001
Influence of GABAAReceptor γ2Splice Variants on Receptor Kinetics and Isoflurane Modulation
Benkwitz, C., Banks, M. I., & Pearce, R. A. (2004) · Anesthesiology · doi:10.1097/00000542-200410000-00018 · Cited by 28
Wang, C., Li, M., Sawmiller, D. R., Fan, Y., Ma, Y., Tan, J., Ren, Y., & Li, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.028 · Cited by 28
GABAAreceptors as targets for novel anxiolytic drugs
Rupprecht, R., Eser, D., Zwanzger, P., & Möller, H. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600868525 · Cited by 28
Nakafero, G., Sanders, R., Nguyen‐Van‐Tam, J. S., & Myles, P. R. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3799 · Cited by 28
Akbar, S., Subhan, F., Karim, N., Aman, U., Ullah, S., Shahid, M. M., Ahmad, N., Fawad, K., & Sewell, R. D. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.047 · Cited by 28
Duke, A. N., Meng, Z., Platt, D. M., Atack, J. R., Dawson, G. R., Reynolds, D. S., Tiruveedhula, V. V. N. P. B., Li, G., Stephen, M. R., Sieghart, W., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249250 · Cited by 28
Fiorelli, R., Rudolph, U., Straub, C. J., Feldon, J., & Yee, B. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc0c7 · Cited by 28
Self-citationGeneral Anesthetics Have Additive Actions on Three Ligand Gated Ion Channels
Jenkins, A., Lobo, I. A., Gong, D., Trudell, J. R., Solt, K., Harris, R. A., & Eger, E. I. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31817b70c1 · Cited by 28
Diazepam reduces brain lesion size in a photothrombotic model of focal ischemia in rats
Aerden, L. A. M., Kessels, F., Rutten, B. P. F., Lodder, J., & Steinbusch, H. W. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.083 · Cited by 28
Studying cerebellar circuits by remote control of selected neuronal types with GABA-A receptors
Wisden, W., Murray, A., McClure, C., & Wulff, P. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.029.2009 · Cited by 28
Groves, J. O., Guscott, M. R., Hallett, D. J., Rosahl, T. W., Pike, A. J., Davies, A. L. M., Wafford, K. A., & Reynolds, D. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04890.x · Cited by 28
GABAA receptor complex: Structure and function
Macdonald, R. L., & Olsen, R. W. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch9 · Cited by 28
Heteromeric GABA A receptor structures in positively-modulated active statesPreprint
Miller, P. S., Masiulis, S., Malinauskas, T., Kotecha, A., Rao, S., Chavali, S., Colibus, L. D., Pardon, E., Hannan, S. B., Scott, S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/338343 · Cited by 28
Newman, E. L., Smith, K. S., Takahashi, A., Chu, A., Hwa, L. S., Chen, Y., DeBold, J. F., Rudolph, U., & Miczek, K. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4069-9 · Cited by 27
Self-citationMechanisms of action of general anesthetics
Diao, S., Ni, J., Shi, X., Liu, P., & Xia, W. G. (2014) · Frontiers in bioscience · doi:10.2741/4241 · Cited by 27
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., Cook, J. M., Sarma, P., & Bokonjić, D. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2170-1 · Cited by 27
Fischer, B. D., Atack, J. R., Platt, D. M., Reynolds, D. S., Dawson, G. R., & Rowlett, J. K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2142-y · Cited by 26
Herde, A. M., Benke, D., Ralvenius, W. T., Mu, L., Schibli, R., Zeilhofer, H. U., & Krämer, S. D. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.022 · Cited by 27
Self-citationAlcohol‐Induced Tolerance and Physical Dependence in Mice With Ethanol Insensitive α1 GABAAReceptors
Werner, D. F., Swihart, A., Ferguson, C., Lariviere, W. R., Harrison, N. L., & Homanics, G. E. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00832.x · Cited by 27
Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone
Fleck, M. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033886 · Cited by 27
Mouse Molecular Genetic Technologies: Promise for Psychiatric Research
Tecott, L. H., & Wehner, J. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.995 · Cited by 27
Anderson, A., Belelli, D., Bennett, D. J., Buchanan, K. I., Casula, A. M., Cooke, A., Feilden, H., Gemmell, D. K., Hamilton, N. M., Hutchinson, E. J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010903i · Cited by 27
Goodacre, S. C., Hallett, D. J., Carling, R. W., Castro, J. L., Reynolds, D. S., Pike, A. J., Wafford, K. A., Newman, R. J., Atack, J. R., & Street, L. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.027 · Cited by 27
Towards better benzodiazepines
Wisden, W., & Stephens, D. (1999) · Nature · doi:10.1038/44482 · Cited by 27
Involvement of the GABAA receptor α subunit in the mode of action of etifoxine
Mattei, C., Taly, A., Soualah, Z., Saulais, O., Henrion, D., Guérineau, N. C., Verleye, M., & Legros, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.034 · Cited by 26
Anti‐anxiety and sedative profile evaluation of imidazo[1,2‐a]pyridine derivatives
López‐Martínez, M., Salgado‐Zamora, H., Juan, E. R., Zamudio, S., Picazo, O., Campos, E., & Naranjo‐Rodríguez, E. B. (2010) · Drug Development Research · doi:10.1002/ddr.20382 · Cited by 26
Selective labelling of diazepam‐insensitive GABA A receptors in vivo using [ 3 H]Ro 15‐4513
Pym, L. J., Cook, S. M., Rosahl, T. W., McKernan, R. M., & Atack, J. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706392 · Cited by 26
Eaton, M. M., Cao, L. Q., Chen, Z., Franks, N. P., Evers, A. S., & Akk, G. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.100347 · Cited by 26
Identification and characterization of anesthetic targets by mouse molecular genetics approaches
Drexler, B., Antkowiak, B., Engin, E., & Rudolph, U. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9414-1 · Cited by 26
Self-citationFollesa, P., Biggio, F., Mancuso, L., Cabras, S., Caria, S., Gorini, G., Manca, A., Orrù, A., & Biggio, G. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.011 · Cited by 26
Rabe, H., Kronbach, C., Rundfeldt, C., & Lüddens, H. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.013 · Cited by 26
Research progress on the neural circuits mechanisms of anxiety
Gong, W. (2025) · Frontiers in Neural Circuits · doi:10.3389/fncir.2025.1609145 · Cited by 25
Discovering new biology with drug-resistance alleles
Freedy, A. M., & Liau, B. B. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00865-9 · Cited by 25
Sanna, E., Busonero, F., Talani, G., Mostallino, M. C., Mura, M. L., Pisu, M. G., Maciocco, E., Serra, M., & Biggio, G. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.047 · Cited by 25
Shen, H., Mohammad, A., Ramroop, J., & Smith, S. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.033 · Cited by 25
Decreased GABA A and GABA B receptor functional activity in cannabinoid CB 1 receptor knockout mice
Urigüen, L., García‐Gutiérrez, M. S., & Manzanares, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358204 · Cited by 25
Tornberg, J., Segerstråle, M., Kulesskaya, N., Võikar, V., Taira, T., & Airaksinen, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301195 · Cited by 25
Gomha, S. M., Abdel‐aziz, H. M., Abolibda, T. Z., Hassan, S., & Abdalla, M. M. (2020) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3827 · Cited by 25
Pharmacology of GABA and Its Receptors
Kaur, S., Singh, S., Arora, A., Ram, P., Kumar, S., Kumar, P., & Abed, S. N. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_8 · Cited by 25
Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome
Purcarin, G., & Ng, Y. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285614521314 · Cited by 25
Physiology and Pharmacology of the GABA System: Focus on GABA Receptors
Möhler, H. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_1 · Cited by 26
Self-citationAlterations in GABAA Receptor α2 Subunit mRNA Expression following Reproductive Experience in Rats
Byrnes, E. M., Lee, J. O., & Bridges, R. S. (2007) · Neuroendocrinology · doi:10.1159/000102535 · Cited by 25
Genes and neurons: molecular insights to fear and anxiety
Stoppel, C. M., Albrecht, A., Pape, H., & Stork, O. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00229.x · Cited by 25
Hypoxia alters GABAA receptor function and subunit expression in NT2-N neurons
Gao, L., Lyons, A. M., & Greenfield, L. J. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.008 · Cited by 25
Functions of GABAA-Receptors: Pharmacology and Pathophysiology
Möhler, H. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56833-6_3 · Cited by 25
Self-citationActions at GABAA receptors in the hippocampus may mediate some antiseizure effects of progestins
Rhodes, M. E., & Frye, C. A. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.02.006 · Cited by 25
Blednov, Y. A., Borghese, C. M., Dugan, M. P., Pradhan, S., Thodati, T. M., Kichili, N. R., Harris, R. A., & Messing, R. O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108220 · Cited by 24
Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
Kaplan, K., & Hunsberger, H. C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1257030 · Cited by 24
Soto, P. L., Ator, N. A., Rallapalli, S., Biawat, P., Clayton, T., Cook, J. M., & Weed, M. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.137 · Cited by 24
Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepam
Pantazis, C. B., & Aston‐Jones, G. (2019) · Addiction Biology · doi:10.1111/adb.12742 · Cited by 24
Nilsson, J., Nielsen, E. Ø., Liljefors, T., Nielsen, M., & Sterner, O. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.092 · Cited by 24
Brown, L. E., Nicholson, M. W., Arama, J., Mercer, A., Thomson, A. M., & Jovanovic, J. N. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714790 · Cited by 24
Mathiasen, L., Rodgers, R. J., & Mirza, N. R. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32814fcdd4 · Cited by 24
Cupello, A. (2003) · Amino Acids · doi:10.1007/s00726-002-0350-4 · Cited by 24
Fine mapping of a sedative‐hypnotic drug withdrawal locus on mouse chromosome 11
Hood, H. M., Metten, P., Crabbe, J. C., & Buck, K. J. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00122.x · Cited by 24
Costanzo, A., Guerrini, G., Ciciani, G., Bruni, F., Costagli, C., Selleri, S., Besnard, F., Costa, B., Martini, C., & Malmberg‐Aiello, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020944u · Cited by 24
Mitchinson, A., Atack, J. R., Blurton, P., Carling, R. W., Castro, J. L., Curley, K. S., Russell, M. G. N., Marshall, G. R., McKernan, R. M., Moore, K. W., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.085 · Cited by 24
Atack, J. R., Pike, A., Clarke, A., Cook, S. M., Sohal, B., McKernan, R. M., & Dawson, G. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006973 · Cited by 23
Specificity protein 4 (Sp4) transcriptionally regulates inhibitory GABAergic receptors in neurons
Nair, B. J., Johar, K., Priya, A., & Wong‐Riley, M. T. T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.005 · Cited by 23
Li, P., Bracamontes, J. R., Manion, B. D., Mennerick, S. J., Steinbach, J. H., Evers, A. S., & Akk, G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12861 · Cited by 23
Influence of GABAA Receptor α Subunit Isoforms on the Benzodiazepine Binding Site
Lüscher, B. P., Baur, R., Goeldner, M. P., & Sigel, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042101 · Cited by 23
Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task
Zanin, K. A., Patti, C. L., Sanday, L., Fernandes‐Santos, L., Oliveira, L. C., Poyares, D. R., Tufik, S., & Frussa‐Filho, R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2756-3 · Cited by 23
Baas, J. M. P., Mol, N., Kenemans, J. L., Prinssen, E. P. M., Niklson, I. A., Xia-Chen, C., Broeyer, F. J. F., & van Gerven, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1516-5 · Cited by 23
Benzodiazepines: Sample Preparation and HPLC Methods for Their Determination in Biological Samples
Samanidou, V., Uddin, M. N., & Papadoyannis, I. N. (2009) · Bioanalysis · doi:10.4155/bio.09.43 · Cited by 23
New 1,5-benzodiazepine compounds: activity at native GABAA receptors
Gatta, E., Cupello, A., Braccio, M. D., Grossi, G., Ferruzzi, R., Roma, G., & Robello, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.013 · Cited by 23
Guerrini, G., Ciciani, G., Cambi, G., Bruni, F., Selleri, S., Besnard, F., Montali, M., Martini, C., Ghelardini, C., Galeotti, N., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.053 · Cited by 23
Heat Loss, Sleepiness, and Impaired Performance after Diazepam Administration in Humans
Echizenya, M., Mishima, K., Satoh, K., Kusanagi, H., Sekine, A., Ohkubo, T., Shimizu, T., & Hishikawa, Y. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300160 · Cited by 23
Laere, K. V., Bormans, G. M., Bohorquez, S. M. S., de Groot, T., Dupont, P. J., Lepeleire, I. D., Hoon, J. N. J. M. D., Mortelmans, L. A., Hargreaves, R. J., Atack, J. R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.021 · Cited by 23
Harris, D. L., & Loew, G. H. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00185-1 · Cited by 23
The GABA A Receptor: Subunit-Dependent Functions and Absence Seizures
Wong, C. G.-T., & Snead, O. C. (2001) · Epiliepsy currents/Epilepsy currents · doi:10.1046/j.1535-7597.2001.00009.x · Cited by 23
Agents in Development for Anxiety Disorders: Current Status and Future Potential
Hood, S. D., Argyropoulos, S. V., & Nutt, D. (2000) · CNS Drugs · doi:10.2165/00023210-200013060-00004 · Cited by 23
Paronis, C. A., Cox, E. D., Cook, J. R., & Bergman, J. (2001) · Psychopharmacology · doi:10.1007/s002130100754 · Cited by 23
Neumann, E., Rudolph, U., Knutson, D. E., Li, G., Cook, J. M., Hentschke, H., Antkowiak, B., & Drexler, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01523 · Cited by 22
Self-citationInhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain
Lorenz‐Guertin, J. M., Povysheva, N. V., Chapman, C. A., MacDonald, M. L., Fazzari, M., Nigam, A., Nuwer, J. L., Das, S., Brady, M. L., Vajn, K., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106248 · Cited by 22
Jacobson‐Pick, S., Audet, M., McQuaid, R. J., Kalvapalle, R., & Anisman, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.038 · Cited by 22
Caffeine Protects Against Anticonvulsant-Induced Impaired Neurogenesis in the Developing Rat Brain
Endesfelder, S., Weichelt, U., Schiller, C., Winter, K., von Haefen, C., & Bührer, C. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9872-8 · Cited by 22
Wu, A., Yu, Q., Lu, H., Lou, Z., Zhao, Y., Luo, T., Fu, Z., & Jin, Y. (2021) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2021.109081 · Cited by 22
Targeting prefrontal cortex GABAergic microcircuits for the treatment of alcohol use disorder
Fish, K. N., & Joffe, M. E. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.936911 · Cited by 22
Atack, J. R. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_2 · Cited by 22
Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABAA receptors
Lager, E., Nilsson, J., Nielsen, E. Ø., Nielsen, M., Liljefors, T., & Sterner, O. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.049 · Cited by 22
Nilsson, J., Gidlöf, R., Nielsen, E. Ø., Liljefors, T., Nielsen, M., & Sterner, O. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.11.050 · Cited by 22
Treatment of Juvenile Myoclonic Epilepsy
Auvin, S. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00046.x · Cited by 22
Xie, J.-F., Fan, K., Wang, C., Xie, P., Hou, M., Xin, L., Cui, G.-F., Wang, L., Shao, Y.-F., & Hou, Y.-P. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2247-3 · Cited by 22
Benoit, S., Chaumontet, C., Schwarz, J., Cakir‐Kiefer, C., Tomé, D., & Miclo, L. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.014 · Cited by 22
Fahey, J. M., Grassi, J. M., Reddi, J. M., & Greenblatt, D. J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.12.006 · Cited by 22
Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice
Smith, K. S., Meloni, E. G., Myers, K. M., Veer, A. V., Carlezon, W. A., & Rudolph, U. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2026-1 · Cited by 22
Self-citationChronic cocaine differentially affects diazepam’s anxiolytic and anticonvulsant actions
Lilly, S. M., & Tietz, E. I. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02858-4 · Cited by 22
Perouansky, M. A., Hentschke, H., Perkins, M. G., & Pearce, R. A. (2007) · Anesthesiology · doi:10.1097/01.anes.0000267600.09764.af · Cited by 22
Stephens, D. N., Mead, A. N., & Ripley, T. L. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00004 · Cited by 22
Solid-Phase Synthesis of Trisubstituted Benzo[1,4]-Diazepin-5-one Derivatives
Fülöpová, V., Gucký, T., Grepl, M., & Soural, M. (2012) · ACS Combinatorial Science · doi:10.1021/co300124q · Cited by 21
Molecular mode of action of CGS 9895 at α1β2γ2 GABAA receptors
Maldifassi, M. C., Baur, R., & Sigel, E. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13711 · Cited by 21
Pentameric Ligand-Gated Ion Channels as Pharmacological Targets Against Chronic Pain
Lara, C. O., Burgos, C. F., Moraga‐Cid, G., Carrasco, M. A., & Yévenes, G. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00167 · Cited by 21
Gong, G., Chen, H., Kam, H., Chan, G., Tang, Y., Wu, M., Tan, H., Tse, Y.-C., Xu, H., & Lee, S. M. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00963 · Cited by 21
Antonio, R. D. L., Kozasa, E. H., Galduróz, J. C. F., Dawa, Dorjee, Y., Kalsang, T., Norbu, T., Tenzin, T., & Rodrigues, E. (2012) · Phytotherapy Research · doi:10.1002/ptr.4749 · Cited by 21
Guerrini, G., Ciciani, G., Bruni, F., Selleri, S., Martini, C., Daniele, S., Ghelardini, C., Mannelli, L. D. C., & Costanzo, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.047 · Cited by 21
de Haas, S., Zoethout, R., Dyck, K. V., Smet, M. D., Rosen, L., Murphy, M., Gottesdiener, K., Schoemaker, R. C., Cohen, A., & van Gerven, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111415731 · Cited by 21
Vijayan, R., Bera, I., Manoharan, P., Saha, S., & Ghoshal, N. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900309s · Cited by 21
Geracitano, R., Fischer, D., Kasugai, Y., Ferraguti, F., & Capogna, M. (2012) · Frontiers in Neural Circuits · doi:10.3389/fncir.2012.00032 · Cited by 21
Nathanson, A. J., Zhang, Y., Smalley, J. L., Ollerhead, T. A., Santos, M. A. R., Andrews, P. M., Wobst, H. J., Moore, Y. E., Brandon, N. J., Hines, R. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.014 · Cited by 21
Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy
Ruscito, B. J., & Harrison, N. L. (2003) · Blood · doi:10.1182/blood-2003-03-0739 · Cited by 21
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.